343 related articles for article (PubMed ID: 26752044)
1. Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells.
Morata-Tarifa C; Jiménez G; García MA; Entrena JM; Griñán-Lisón C; Aguilera M; Picon-Ruiz M; Marchal JA
Sci Rep; 2016 Jan; 6():18772. PubMed ID: 26752044
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.
Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J
Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
[TBL] [Abstract][Full Text] [Related]
5. B7H1 Expression and Epithelial-To-Mesenchymal Transition Phenotypes on Colorectal Cancer Stem-Like Cells.
Zhi Y; Mou Z; Chen J; He Y; Dong H; Fu X; Wu Y
PLoS One; 2015; 10(8):e0135528. PubMed ID: 26284927
[TBL] [Abstract][Full Text] [Related]
6. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.
Knezevic J; Pfefferle AD; Petrovic I; Greene SB; Perou CM; Rosen JM
Oncogene; 2015 Dec; 34(49):5997-6006. PubMed ID: 25746005
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
8. A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics.
Harner-Foreman N; Vadakekolathu J; Laversin SA; Mathieu MG; Reeder S; Pockley AG; Rees RC; Boocock DJ
Sci Rep; 2017 Jan; 7():40633. PubMed ID: 28094783
[TBL] [Abstract][Full Text] [Related]
9. Cells susceptible to epithelial-mesenchymal transition are enriched in stem-like side population cells from prostate cancer.
Luo Y; Cui X; Zhao J; Han Y; Li M; Lin Y; Jiang Y; Lan L
Oncol Rep; 2014 Feb; 31(2):874-84. PubMed ID: 24316717
[TBL] [Abstract][Full Text] [Related]
10. EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells.
Xu MH; Gao X; Luo D; Zhou XD; Xiong W; Liu GX
PLoS One; 2014; 9(2):e87893. PubMed ID: 24516569
[TBL] [Abstract][Full Text] [Related]
11. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
12. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
13. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
[TBL] [Abstract][Full Text] [Related]
14. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
15. BMP-4 enhances epithelial mesenchymal transition and cancer stem cell properties of breast cancer cells via Notch signaling.
Choi S; Yu J; Park A; Dubon MJ; Do J; Kim Y; Nam D; Noh J; Park KS
Sci Rep; 2019 Aug; 9(1):11724. PubMed ID: 31409851
[TBL] [Abstract][Full Text] [Related]
16. Spheres derived from the human SN12C renal cell carcinoma cell line are enriched in tumor initiating cells.
Zhang Y; Sun B; Zhao X; Sun H; Cui W; Liu Z; Yao X; Dong X
J Exp Clin Cancer Res; 2016 Oct; 35(1):163. PubMed ID: 27756344
[TBL] [Abstract][Full Text] [Related]
17. Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549.
Tièche CC; Gao Y; Bührer ED; Hobi N; Berezowska SA; Wyler K; Froment L; Weis S; Peng RW; Bruggmann R; Schär P; Amrein MA; Hall SRR; Dorn P; Kocher G; Riether C; Ochsenbein A; Schmid RA; Marti TM
Neoplasia; 2019 Feb; 21(2):185-196. PubMed ID: 30591423
[TBL] [Abstract][Full Text] [Related]
18. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
[TBL] [Abstract][Full Text] [Related]
20. SNAIL induces epithelial-to-mesenchymal transition and cancer stem cell-like properties in aldehyde dehydroghenase-negative thyroid cancer cells.
Yasui K; Shimamura M; Mitsutake N; Nagayama Y
Thyroid; 2013 Aug; 23(8):989-96. PubMed ID: 23432420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
